The polymorphism of catalase gene C-262T: Impact on ulcerative colitis

Abstract

Ulcerative Colitis is a chronic inflammatory disease of the digestive tract. Reactive oxygen species (ROS) causes inflammation and are thought to play a role in the pathophysiology of Inflammatory Bowel Disease (IBD). Catalase, one of the antioxidant enzymes, decomposes hydrogen peroxide into oxygen and water and protects the cells from oxidative damage of reactive oxygen species. It has been reported that CAT gene promoter polymorphism has a protective effect on oxidative stress-related diseases. The aim of this study was to investigate the association of catalase C-262T polymorphism with ulcerative colitis and to determine whether CATC-262T polymorphism is a risk factor for the disease. We investigated 80 patients with ulcerative colitis and 90 controls in the Black Sea region in Turkey. After blood sampling, DNA was extracted from the peripheral blood, then we design 2 sets of primers for C and T alleles. The polymorphism was determined by using PCR technique and the statistical analysis was performed by Kolmogorov-Smirnow test. There were no significant association between frequencies of the CATC-262Ts of the case and the control groups and genotype frequencies were very similar (P=0.996). This is the first report in regard to the association of CATC-262T polymorphism with ulcerative colitis in the Black Sea region in the Turkish population. According to the results of this study there were no significant differences in the genotype distribution and allelic frequency between patients and control groups.

Keywords

• Ulcerative colitis
• Catalase
• ROS
• Allele frequency

References

1. 1. Ahmed I, Niaz Z. Ulcerative Colitis. O'Connor M, eds. Epidemiology, Pathogenesis and Complications. IntechOpen. 2011; p.1-12. doi: 10.5772/25591.
2. 2. Yang CJ, Chung CH, Chen SJ, et al. Association between aortic aneurysm and ulcerative colitis: A nationwide taiwanese retrospective cohort study. Journal of Medical Sciences. 2019; 39(2): 74. doi: 10.4103/jmedsci.jmedsci_99_18.
3. 3. Shen ZH, Zhu CX, Quan YS, et al. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation. world journal of gastroenterol. 2018; 24(1): 5. doi: 10.3748/wjg.v24.i1.5.
4. 4. Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019; 156(8): 2174-2189. doi: 10.1053/j.gastro.2019.03.017.
5. 5. Aydoğan F. İnflamatuvar Barsak Hastalığında P-Anca ve Asca’nın Klinik Önemleri. Uzmanlık Tezi, Okmeydanı Eğitim ve Araştırma Hastanesi, İstanbul, TR, 2009.
6. 6. Gajendran M, Loganathan P, Jimenez G, et al. A comprehensive review and update on ulcerative colitis. Disease-a-month 2019; 65(12): 100851. doi: 10.1016/j.disamonth.2019.02.004.
7. 7. Tysk C, Lindberg E, Järnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988; 29(7): 990. doi: 10.1136/gut.29.7.990.
8. 8. Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World journal of gastroenterology. 2014; 20(1): 91. doi: 10.3748/wjg.v20.i1.91.

9. 9. Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Experimental biology and medicine (Maywood, N.J.). 2012; 237(5): 474-480.
10. 10. Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cellular and molecular life sciences. 2004; 61(2): 192-208.
11. 11. Ahn J, Gammon MD, Santella RM, et al. Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. American journal of epidemiology. 2005; 162(10): 943-952.
12. 12. Choi J-Y, Neuhouser ML, Barnett M, et al. Polymorphisms in oxidative stress–related genes are not associated with prostate cancer risk in heavy smokers. Cancer epidemiology, biomarkers & prevention. 2007; 16(6): 1115-1120.
13. 13. Khodayari S, Salehi Z, Fakhrieh Asl S, Aminian K, Mirzaei Gisomi N, Torabi Dalivandan S. Catalase gene C‐262T polymorphism: Importance in ulcerative colitis. Journal of gastroenterology and hepatology. 2013; 28(5): 819-822.
14. 14. Lopes RH, Reid I, Hobson PR(Internet). The two-dimensional Kolmogorov-Smirnov test. Available from: [https://pdfs.semanticscholar.org/1cf6/fa61f4d7c2fc2848822274ed07ee69889a59.pdf](https://pdfs.semanticscholar.org/1cf6/fa61f4d7c2fc2848822274ed07ee69889a59.pdf)
15. 15. Güçyener EY. Katalaz 262 C/Tpolimorfizminin baş ve boyun bölgesi hastalarında araştırılması. (dissertation). Ankara Üniversitesi Sağlık Bilimleri Enstitüsü, Ankara, TR, 2009.
16. 16. Ho JC, Mak JC, Ho S, et al. Manganese superoxide dismutase and catalase genetic polymorphisms, activity levels, and lung cancer risk in Chinese in Hong Kong. Journal of Thoracic Oncology. 2006; 1(7): 648-653.
17. 17. Mak J, Leung H, Ho S, et al. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2006; 36(4): 440-447.
18. 18. Ho YS, Xiong Y, Ma W, Spector A, Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J The Journal of biological chemistry. 2004; 279(31): 32804-32812.
19. 19. Ateş N, Yildirim Ö, Tamer L, et al. Plasma catalase activity and malondialdehyde level in patients with cataract. Eye (London, England). 2004; 18(8): 785-788.
20. 20. Forsberg L, Lyrenäs L, Morgenstern R, de Faire U. A common functional CT substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free radical biology & medicine. 2001; 30(5): 500-505.
21. 21. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. The FASEB Journal. 2003; 17(10): 1195-1214.
22. 22. Ahn J, Nowell S, McCann SE, et al. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer epidemiology, biomarkers & prevention. 2006; 15(6): 1217-1222.
23. 23. Ding G, Liu F, Shen B, Feng C, Xu J, Ding Q. The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality. Clinical genitourinary cancer. 2012; 10(4): 251-255.
24. 24. Tefik T, Kucukgergin C, Sanli O, Oktar T, Seckin S, Ozsoy C. Manganese superoxide dismutase Ile58Thr, catalase C‐262T and myeloperoxidase G‐463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease. BJU international. 2013; 112(4): E406-E414.
25. 25. Geybels MS, van den Brandt PA, van Schooten FJ, Verhage BA. Oxidative Stress–Related Genetic Variants, Pro-and Antioxidant Intake and Status, and Advanced Prostate Cancer Risk. Cancer epidemiology, biomarkers & prevention. 2015; 24(1): 178-186.
26. 26. Hu J, Feng F, Zhu S, et al. Catalase C-262T polymorphism and risk of prostate cancer: evidence from meta-analysis.
27. 27. Jamhiri I, Saadat I, Omidvari S. Genetic polymorphisms of superoxide dismutase-1 A251G and catalase C-262T with the risk of colorectal cancer. Molecular biology research communications. 2017; 6(2): 85.
28. 28. Chistiakov D, Zotova E, Savost'anov K, et al. The 262T> C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes & Metabolism. 2006; 32(1): 63-68.
29. 29. Zotova E, Chistyakov D, Savost'yanov E, et al. Association of the SOD2 Ala (–9) Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1. Molecular Biology. 2003; 37(3): 345-348.
30. 30. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Molecular and cellular biochemistry. 2004; 266(1-2): 37-56.